Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients

Urology

Volumn 67, Issue 1, 2006, Pages 131-136

  Suzuki, Hiroyoshi ^a   Komiya, Akira ^b   Kamiya, Naoto ^b   Imamoto, Takashi ^b   Kawamura, Koji ^b   Miura, Junichiro ^b   Suzuki, Noriyuki ^b   Nakatsu, Hiroomi ^b   Hata, Akira ^b   Ichikawa, Tomohiko ^b  

^a CHIBA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PATIENT REFERRAL; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; BIOPSY; HUMANS; JAPAN; MALE; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 30344457913     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.07.040     Document Type: Article

References (19)

1. A. Shibata, J. Ma, A.S. Whittemore Prostate cancer incidence and mortality in the United States and the United Kingdom J Natl Cancer Inst 90 1998 1230 1231
2. G. Bartsch, W. Horninger, H. Klocker Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria Urology 58 2001 417 424
3. A. Bill-Axelson, L. Holmberg, M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977 1984
4. K. Kamoi, R.J. Babaian Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer Semin Oncol 26 1999 140 149
5. W.J. Catalona, A.W. Partin, K.M. Slawin Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease a prospective multicenter clinical trial JAMA 279 1998 1542 1547
6. H. Suzuki, K. Akakura, T. Igarashi Clinical usefulness of serum anti-p53 antibodies for prostate cancer detection a comparative study with PSA parameters J Urol 171 2004 182 186
7. L.V. Rodriguez, M.K. Terris Risks and complications of transrectal ultrasound guided prostate needle biopsy a prospective study and review of the literature J Urol 160 1998 2115 2120
8. G.D. Carlson, C.B. Calvanese, A.W. Partin An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer results on 4298 cases Urology 52 1998 455 461
9. J.A. Eastham, R. May, J.L. Robertson Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL Urology 54 1999 709 713
10. S.R. Potter, W. Horniger, M. Tinzl Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer Urology 57 2001 1100 1104
11. M. Ohori, P. Swindle Nomograms and instruments for the initial prostate evaluation the ability to estimate the likelihood of identifying prostate cancer Semin Urol Oncol 20 2002 116 122
12. B. Djavan, M. Remzi, A. Zlotta Novel artificial neural network for early detection of prostate cancer J Clin Oncol 20 2002 921 929
13. M.W. Kattan, J.A. Eastham, A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
14. F.H. Schroder, I. van der Cruijsen-Koeter, H.J. de Koning Prostate cancer detection at low prostate specific antigen J Urol 163 2000 806 812
15. M. Garzotto, R.G. Hudson, L. Peters Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen <10 ng/mL Cancer 98 2003 1417 1422
16. E. Lopez-Corona, M. Ohori, P.T. Scardino A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session J Urol 170 2003 1184 1188
17. M. Kattan Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic" J Clin Oncol 20 2002 885 887
18. J.C. Presti Jr, G.J. O'Dowd, M.C. Miller Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates results of a community multi-practice study J Urol 169 2003 125 129
19. P. Emiliozzi, P. Scarpone, F. DePaula The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml a randomized study of 6 versus 12 core transperineal prostate biopsy J Urol 171 2004 197 199